ARCHIVES

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

This article is from The Cancer Letter archive.

Vol. 03 No. 34 | August 26, 1977

Download PDF Visit The Full Archive

Related Articles

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

NCI, ACRIN Begin Trial Comparing Digital Mammography To Standard.

September 7, 2001

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010

Patient’s Husband To Fund Fellowship At Dana-Farber

September 8, 1995